Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Melissa L. Pilewskie"'
1
Axillary Staging Is Not Justified in Postmenopausal Clinically Node-Negative Women Based on Nodal Disease Burden
Autor: Minna K, Lee, Giacomo, Montagna, Melissa L, Pilewskie, Varadan, Sevilimedu, Monica, Morrow
Publikováno v: Annals of Surgical Oncology. 30:92-97
RxPONDER showed no benefit of adjuvant chemotherapy in postmenopausal women with estrogen receptor (ER) positive/human epidermal growth factor receptor 2 (HER2) negative breast cancer and limited nodal burden (pN1) with a recurrence score ≤ 25, sug
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45b73742018ae0fea003efd229de9090
https://doi.org/10.1245/s10434-022-12203-x
Zobrazit plný text záznamu
3
Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy
Autor: Sarah Shubeck, Varadan Sevilimedu, Elizabeth Berger, Mark Robson, Alexandra S. Heerdt, Melissa L. Pilewskie
Publikováno v: Annals of Surgical Oncology. 29:4706-4713
Although outcomes are similar following breast-conserving surgery (BCS) or mastectomy among sporadic breast cancer patients, data are mixed for women with a germline BRCA mutation. We sought to compare outcomes among a modern cohort of BRCA mutation
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::359cb7f156c76bdb6aa8ac838b5a55c6
https://doi.org/10.1245/s10434-022-11756-1
Zobrazit plný text záznamu
7
Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ
Autor: Melissa Anne Mallory, Karissa Whiting, Anna Park, Mithat Gönen, Elizabeth Gilbert, Tari A. King, Melissa L. Pilewskie
Publikováno v: Breast cancer research and treatment. 194(1)
Lobular carcinoma in situ (LCIS) confers increased cancer risk in either breast, but it remains unclear if this population is at increased risk for bilateral breast cancer (BC) development. Here we report bilateral BC incidence among women with a his
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760764798835402ddc3e4ceebab42d33
https://pubmed.ncbi.nlm.nih.gov/35488092
Zobrazit plný text záznamu
9
Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ
Autor: Elizabeth, Shurell, Cristina, Olcese, Sujata, Patil, Beryl, McCormick, Kimberly J, Van Zee, Melissa L, Pilewskie
Publikováno v: Cancer. 124(1)
The current study was conducted to examine the association between ipsilateral breast tumor recurrence (IBTR) and the timing of radiotherapy (RT) in women with ductal carcinoma in situ (DCIS) undergoing breast-conserving surgery (BCS).Women with DCIS
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7ba9fd6da7cfa78fffe9627b8a7b6cdb
https://pubmed.ncbi.nlm.nih.gov/28960259
Zobrazit plný text záznamu
10
Management of the clinically node-negative axilla: what have we learned from the clinical trials?
Autor: Melissa L, Pilewskie, Monica, Morrow
Publikováno v: Oncology (Williston Park, N.Y.). 28(5)
Sentinel lymph node biopsy (SLNB) has revolutionized the surgical management of the axilla for patients with early breast cancer. SLNB initially became standard regional therapy for women who were both clinically and pathologically node-negative. Sub
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a0f48ffd26b1970244ed768cfdd98264
https://pubmed.ncbi.nlm.nih.gov/25004650
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje